Literature DB >> 26004373

WHO includes 16 new cancer drugs on list of essential medicines.

Susan Mayor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26004373     DOI： 10.1016/S1470-2045(15)70240-8

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Availability, Affordability, Access, and Pricing of Anti-cancer Medicines in Low- and Middle-Income Countries: A Systematic Review of Literature.

Authors:  Phyllis Ocran Mattila; Rabbiya Ahmad; Syed Shahzad Hasan; Zaheer-Ud-Din Babar
Journal:  Front Public Health       Date:  2021-04-30

2.  Approval status and evidence for WHO essential medicines for children in the United States, United Kingdom, and Japan: a cross-sectional study.

Authors:  Rumiko Shimazawa; Masayuki Ikeda
Journal:  J Pharm Policy Pract       Date:  2017-01-06

Review 3.  An update on the management of breast cancer in Africa.

Authors:  V Vanderpuye; S Grover; N Hammad; H Simonds; F Olopade; D C Stefan
Journal:  Infect Agent Cancer       Date:  2017-02-14       Impact factor: 2.965

4.  Differences in reimbursement listing of anticancer therapies in China: an observational study.

Authors:  Xiaodong Guan; Yichen Zhang; Haishaerjiang Wushouer; Luwen Shi; Dennis Ross-Degnan; Anita Katharina Wagner
Journal:  BMJ Open       Date:  2020-01-06       Impact factor: 2.692
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.